Transgenic expression of AOX in mammalian systems has been suggested as a therapeutic option for treating mitochondrial disease induced by OXPHOS dysfunction39, and additionally it has been shown that even broad expression of AOX does not disturb normal physiology in mice40. Here, ACOX1 is linked to mitochondrial disease.